Provident Healthcare Partners Advises Acentus in its Acquisition by Henry Schein
Rhea-AI Summary
Henry Schein (HSIC) has completed the acquisition of substantially all assets of Acentus, a national medical supplier specializing in Continuous Glucose Monitors (CGMs). The deal, initially announced on November 20, 2024, brings Acentus founders Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia into Henry Schein's team, incorporating their healthcare industry and product expertise.
The transaction was facilitated by Provident Healthcare Partners, with their deal team led by Managing Director Kevin Palamara. Robinson & Cole provided legal counsel to Acentus during the acquisition process. Acentus has developed a distinctive CGM platform that has shown significant growth since its establishment.
Positive
- Acquisition expands Henry Schein's presence in the growing CGM market
- Integration of Acentus's experienced leadership team strengthens expertise
- Acquisition of established CGM platform with proven growth track record
Negative
- None.
News Market Reaction – HSIC
In the trading session that priced this news, HSIC gained 0.84%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Provident's deal team was led by Managing Director Kevin Palamara. Robinson & Cole served as legal counsel to Acentus. The agreement to acquire Acentus was announced on November 20, 2024.
"Hats off to the entire Provident team. They brought unmatched expertise, experience, and dedication to the process and their guidance and professionalism throughout the transaction exceeded all our expectations," commented Todd Cianfrocca, CEO of Acentus.
"Congratulations to Acentus on this significant achievement. It has been a pleasure working alongside Todd and his entire team throughout this process," commented Palamara.
"Todd and the Acentus team have developed a unique and differentiated CGM platform that has realized tremendous growth since its inception. We were proud to represent them through this process and are incredibly excited to see where this partnership with Henry Schein will take them going forward," stated Brendan Schroeder, Senior Associate at Provident.
About Acentus
Headquartered in
About Henry Schein
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 26,000 Team Schein Members worldwide, the company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in
About Provident Healthcare Partners
Provident is a leading healthcare investment banking firm specializing in merger and acquisition advisory, strategic planning, and capital formation services for healthcare companies. The firm has a comprehensive knowledge of market sectors and specialties, including the durable medical equipment (DME) industry. Provident also has unsurpassed experience and insight into the M&A process, which includes working with a multitude of investors such as private equity firms and strategic consolidators. For additional information, visit www.providenthp.com and follow Provident on LinkedIn.
Contact: | |
Provident Healthcare Partners | |
877-742-9800 | |
gcasiello@providenthp.com |
View original content to download multimedia:https://www.prnewswire.com/news-releases/provident-healthcare-partners-advises-acentus-in-its-acquisition-by-henry-schein-302352624.html
SOURCE Provident Healthcare Partners LLC